GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: compound 3 [PMID: 28753313] | SAGE-217 | SAGE217 | Zurzuvae®
                                 
                                                         
                            
                            
                            
                                 
                                
                                zuranolone is an approved drug (FDA (2023)) 
                                                        
                                                    
                                Compound class: 
                                                            Synthetic organic
                                 
                                
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                     | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
| References | 
| 
                                                                         1. Carvalho T. (2023)
                                         New depression drug zuranolone one step closer to FDA ruling. Nat Med, 29 (5): 1032-1033. [PMID:37041352]  | 
                                                                
| 
                                                                         2. Cutler AJ, Mattingly GW, Maletic V. (2023)
                                         Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder. Transl Psychiatry, 13 (1): 228. [PMID:37365161]  | 
                                                                
| 
                                                                         3. Deligiannidis KM, Meltzer-Brody S, Maximos B, Peeper EQ, Freeman M, Lasser R, Bullock A, Kotecha M, Li S, Forrestal F et al.. (2023)
                                         Zuranolone for the Treatment of Postpartum Depression. Am J Psychiatry, 180 (9): 668-675. [PMID:37491938]  | 
                                                                
| 
                                                                         4. Martinez Botella G, Salituro FG, Harrison BL, Beresis RT, Bai Z, Blanco MJ, Belfort GM, Dai J, Loya CM, Ackley MA et al.. (2017)
                                         Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1'-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid)A Receptor. J Med Chem, 60 (18): 7810-7819. [PMID:28753313]  |